The use of an independent antibody directed against the N-terminal, soluble domain of DLK1 also showed specific signal in the perinecrotic tumor areas (Supplementary Figure 2) and co-staining of GFAP and DLK1 (Figure 1D−E, H and Supplementary Figure 1C). The gene discussed is GFAP; the disease is neoplasm.